🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this phase II study is to assess the efficacy of AP23573 in ...
Status
Completed
Location
University of Chicago Hospitals, Section of Hematology/Oncology
Start Date
2004-06
Trial ID
NCT00086125
Treatments Being Tested
The purpose of the study is to evaluate the efficacy of the triplet of rida...
Status
Completed
Location
Multiple Locations
Start Date
2012-07-04
Trial ID
NCT01605396
Treatments Being Tested
This clinical trial will study the use of ridaforolimus in metastatic breas...
Status
Completed
Location
Multiple Locations
Start Date
2008-07
Trial ID
NCT00736970
Treatments Being Tested
Ridaforolimus has been tested in almost 2 dozen studies; however, it has no...
Status
Withdrawn
Location
Cancer Therapy & Research Center at UTHSCSA
Start Date
2011-02
Trial ID
NCT01296659
Treatments Being Tested
The purpose of this study is to assess the antitumor activity of weekly rid...
Status
Completed
Location
Louis Warchaw Prostate Cancer Center, Cedars-Sinai Medical Center
Start Date
2005-05
Trial ID
NCT00110188
Treatments Being Tested
To describe the long-term safety of deforolimus (ridaforolimus, MK-8669) in...
Status
Terminated
Location
Multiple Locations
Start Date
2009-02-01
Trial ID
NCT00836927
Treatments Being Tested
The primary objective of this current phase I trial is to study the safety ...
Status
Completed
Location
Multiple Locations
Start Date
2005-05
Trial ID
NCT00112372
Treatments Being Tested
A clinical study evaluates the safety, tolerability, and pharmacokinetics o...
Status
Completed
Location
Multiple Locations
Start Date
2008-06-10
Trial ID
NCT00694083
Treatments Being Tested
The study will enroll approximately 316 subjects with a wide spectrum of PC...
Status
Completed
Location
Medinol LTD
Start Date
2019-05-06
Trial ID
NCT03877848
Treatments Being Tested
This phase I trial is studying the side effects and best dose of giving rid...
Status
Completed
Location
Fox Chase Cancer Center
Start Date
2010-10
Trial ID
NCT01169532
Treatments Being Tested